Advertisement
Screener

PROMIS NEUROSCIENCES INC. (PMN) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments

1.8 / 5 stars · 19/54 Roast Me

PROMIS NEUROSCIENCES INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments

PROMIS NEUROSCIENCES INC. (PMN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments · last filed 2026-08-13

  • 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 6 month $0.00.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 6 month
2026-06-30$0.00
10-Q · filed 2026-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51